Transcriptional analysis of targets in multiple sclerosis (Q35140810)

6 August 2017

1 reference

title

Transcriptional analysis of targets in multiple sclerosis (English)

1 reference

6 August 2017

0 references

Lawrence Steinman

1

1 reference

6 August 2017

Scott Zamvil

series ordinal

2

1 reference

6 August 2017

publication date

1 June 2003

1 reference

Nature Reviews Immunology

6 August 2017

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

483-492

1 reference

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease

6 August 2017

cites work

1 reference

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

31 March 2020

1 reference

Autoantigen microarrays for multiplex characterization of autoantibody responses

31 March 2020

1 reference

Multiple sclerosis: a two-stage disease

31 March 2020

1 reference

Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy.

31 March 2020

1 reference

An array of sunshine in multiple sclerosis

31 March 2020

1 reference

Significance analysis of microarrays applied to the ionizing radiation response

31 March 2020

1 reference

Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays

31 March 2020

1 reference

cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity

31 March 2020

1 reference

Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions

31 March 2020

1 reference

Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis

31 March 2020

1 reference

Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction

31 March 2020

1 reference

Gene microarrays and experimental demyelinating disease: a tool to enhance serendipity

31 March 2020

1 reference

Receptor-ligand interaction between CD44 and osteopontin (Eta-1)

31 March 2020

1 reference

Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment

31 March 2020

1 reference

Cutting edge: Attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice

31 March 2020

1 reference

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

31 March 2020

1 reference

Osteopontin polymorphisms and disease course in multiple sclerosis

31 March 2020

1 reference

Genetic polymorphisms of osteopontin in association with multiple sclerosis in Japanese patients

31 March 2020

1 reference

Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine

31 March 2020

1 reference

Comment on "The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease"

31 March 2020

1 reference

Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein

31 March 2020

1 reference

B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide

31 March 2020

1 reference

Some misconceptions about understanding autoimmunity through experiments with knockouts

31 March 2020

1 reference

In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis

31 March 2020

1 reference

Statins as a newly recognized type of immunomodulator

31 March 2020

1 reference

Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity

31 March 2020

1 reference

In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor

31 March 2020

1 reference

Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes

31 March 2020

1 reference

Inhibition of experimental autoimmune thyroiditis in mice by anti-I-A antibodies

31 March 2020

1 reference

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

31 March 2020

1 reference

Statins as immunomodulators: comparison with interferon-beta 1b in MS.

31 March 2020

1 reference

Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin

31 March 2020

1 reference

The intricate interplay among body weight, stress, and the immune response to friend or foe.

31 March 2020

1 reference

Requirement for leptin in the induction and progression of autoimmune encephalomyelitis.

31 March 2020

1 reference

Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses

31 March 2020

1 reference

Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss

31 March 2020

1 reference

An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide

31 March 2020

1 reference

OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS

31 March 2020

1 reference

Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination.

31 March 2020

1 reference

Optic Neuritis, A New Variant of Experimental Encephalomyelitis, A Durable Model for All Seasons, Now In Its Seventieth Year

31 March 2020

1 reference

Identification of Bphs, an autoimmune disease locus, as histamine receptor H1.

31 March 2020

1 reference

Millennium Award. Proteomics for the development of DNA tolerizing vaccines to treat autoimmune disease

31 March 2020

1 reference

Proteomics technologies for the study of autoimmune disease

31 March 2020

1 reference

DNA vaccination in the treatment of autoimmune disease

31 March 2020

1 reference

Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway

31 March 2020

1 reference

Immunization with DNA encoding an immunodominant peptide of insulin prevents diabetes in NOD mice

31 March 2020

1 reference

Prevention of experimental autoimmune encephalomyelitis by MIP-1alpha and MCP-1 naked DNA vaccines

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRI1108

1 reference

6 August 2017

1 reference